BETWEEN: Potato Variety Management Institute, Inc., an Idaho nonprofit corporation (“PVMI”)Non-Exclusive Sublicense Agreement • November 21st, 2022 • Idaho
Canadian Independent Seed Grower)Non-Exclusive Sublicense Agreement • October 27th, 2020 • Idaho
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2020Non-Exclusive Sublicense Agreement • December 30th, 2019
RECITALSNon-Exclusive Sublicense Agreement • July 26th, 2000 • Discovery Partners International Inc • Services-commercial physical & biological research • California
AMENDED AND RESTATED NON-EXCLUSIVE SUBLICENSE AGREEMENTNon-Exclusive Sublicense Agreement • June 29th, 2020 • Dyadic International Inc • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Non-Exclusive Sublicense Agreement (“Agreement”) is entered into as of this 24th day of June, 2020 (“Effective Date”) by and between Dyadic International Inc., a Delaware corporation having its principal office at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 (“Sublicensor”), and Alphazyme LLC a Delaware limited liability company having its principal office at 225 Chimney Corner Lane, Suite 3021, Jupiter, Florida 33458 (“Sublicensee”).
NON-EXCLUSIVE SUBLICENSE AGREEMENT Between Apath, L.L.C. And Pharmasset, Inc. For HCV REPLICON And RELATED INTELLECTUAL PROPERTYNon-Exclusive Sublicense Agreement • April 24th, 2007 • Pharmasset Inc • Pharmaceutical preparations • New York
THIS NON-EXCLUSIVE SUBLICENSE AGREEMENT (“Agreement”) is made and entered into August 26, 2005 (the “Effective Date”) by and between Apath, L.L.C., a limited liability company of the State of Missouri, with a business address at 893 N. Warson Road, St. Louis, Missouri 63141 (“Apath”); and Pharmasset, Inc., a Delaware company, with a business address at 303A College Road East, Princeton, New Jersey 08540 (“Pharmasset”). Apath and Pharmasset are hereinafter referred to individually as a “Party” or collectively as “Parties.”
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2018-19 (Independent Grower in the Southern Hemisphere)Non-Exclusive Sublicense Agreement • December 9th, 2017
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2021Non-Exclusive Sublicense Agreement • October 27th, 2020
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2019Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2019Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2019Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2022Non-Exclusive Sublicense Agreement • March 15th, 2022
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2021 (Independent Grower in the Northern Hemisphere)Non-Exclusive Sublicense Agreement • September 29th, 2020
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2020 (Canadian Independent Seed Grower)Non-Exclusive Sublicense Agreement • December 31st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2020-21 (Independent Grower in the Southern Hemisphere)Non-Exclusive Sublicense Agreement • December 31st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2021Non-Exclusive Sublicense Agreement • October 27th, 2020
NON-EXCLUSIVE SUBLICENSE AGREEMENT between PANGEN1X and AviGenics Inc. for Viral Particles Having Altered Host Range (VSV) For Birds 1st Amendment, April 1, 2003Non-Exclusive Sublicense Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • California
THIS SUB-LICENSE AGREEMENT (the “Agreement”) is effective as of 5 December 2000 (the “Effective Date”) between PANGENIX, a California corporation having a place of business at 6505 El Camino del Teatro, La Jolla, CA 92037-6337 (“Pangenix”), as sublicensor, and AviGenics, Inc., a corporation having a place of business at 111 Riverbend Road, Athens, GA -30605.
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2016-17Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2018 (Independent Grower)Non-Exclusive Sublicense Agreement • July 18th, 2017
NON-EXCLUSIVE SUBLICENSE AGREEMENTNon-Exclusive Sublicense Agreement • August 14th, 2015 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2021Non-Exclusive Sublicense Agreement • October 27th, 2020
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2020Non-Exclusive Sublicense Agreement • October 31st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2018Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2022Non-Exclusive Sublicense Agreement • March 15th, 2022
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2022-23Non-Exclusive Sublicense Agreement • March 15th, 2022
NON-EXCLUSIVE SUBLICENSE AGREEMENTNon-Exclusive Sublicense Agreement • August 30th, 2012 • Taylor & Martin Group Inc • Services-business services, nec • Texas
This NON-EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”), effective as of the Effective Date (herein defined below), is between TMG Founder Company (formerly named Taylor & Martin Group, Inc.) a Delaware corporation formed on March 24, 2011 (“Sublicensor”) and Taylor & Martin Group, Inc., a Delaware corporation formed on November 18, 2011 (“Sublicensee”).
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2017-18Non-Exclusive Sublicense Agreement • May 21st, 2019
NON-EXCLUSIVE SUBLICENSE AGREEMENT RENEWAL for 2020Non-Exclusive Sublicense Agreement • December 30th, 2019
